Panolos Bioscience Revenue

Biotechnology Research • 21-gil 10, Dongtan-daero, Korea, Republic of • 1-10 Employees

Panolos Bioscience revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	$17,600,000

Key Contacts at Panolos Bioscience

Hyeseong Lim

Chief Executive Officer

Hyungul Yang

Research Director

Company overview

Headquarters	21-gil 10, Dongtan-daero, Suite #217, Hwaseong-si, Gyeonggi-do 18471, KR
Phone number	+823180550886
Website	panolos.com
NAICS	541714
Founded	2019
Employees	1-10
Socials

About Panolos Bioscience

Panolos Bioscience is a frontrunner in structure-based protein design and development, with a focus on multi-specific drug development. We specialize in creating anti-angiogenic therapies targeting cancer, autoimmune, and rare diseases. Our proprietary "Alpha(α)-ART (Anti-angiogenesis-based Artifact Re-targeting Tri-specific) technology" features a VEGF receptor backbone, enabling the creation of mono- or multi-specific antibody therapeutics with enhanced efficacy. Starting October 2023, PB101 using αART technology is enrolling for Phase I which is manufactured by Samsung Biologics based on a CDMO partnership. Panolos attracted a development partnership with Kelun-Biotech for PB203 (aka, PKB01), and formed the strategic alliance and CDMO partnership with Chime Biologics for the same. Panolos is developing various pipelines targeting PD-L1, EGFR, and TGF-beta(b) To support our ongoing development, Panolos Bioscience raised $18 million in Series A funding and is currently seeking a Series B Bridge investment of $20 million in 2023.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Manager

Employees by Department

Panolos Bioscience has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Panolos Bioscience's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-06-17	4	$17,600,000

Funding Insights

$17,600,000

Total funding amount

$17,600,000

Most recent funding amount

Number of funding rounds

Panolos Bioscience Tech Stack

Discover the technologies and tools that power Panolos Bioscience's digital infrastructure, from frameworks to analytics platforms.

Kakao

Miscellaneous

jQuery CDN

CDN

Amazon Web Services

PaaS

Vue.js

JavaScript frameworks

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Node.js

Programming languages

Nuxt.js

JavaScript frameworks

Swiper

JavaScript libraries

AWS Certificate Manager

SSL/TLS certificate authorities

jsDelivr

CDN

Webpack

Miscellaneous

Frequently asked questions

Panolos Bioscience is located in 21-gil 10, Dongtan-daero, KR.

You can reach Panolos Bioscience at +823180550886.

Panolos Bioscience generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Panolos Bioscience has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Panolos Bioscience was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Panolos Bioscience has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Panolos Bioscience has raised a total of $17,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Panolos Bioscience

Hyeseong Lim

Chief Executive Officer

Hyungul Yang

Research Director

4.8

40,000 users